Schedule 13G ownership disclosure

QUINCE THERAPEUTICS INC

Security class unavailable · CUSIP: 22053A107

Event date: 2021-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,462,465
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001562230-21-000135
Form type
SC 13G/A
Filer
Capital International Investors
CIK
CIK 1562230
Filed
Dec 10, 2021
Reporting period
Nov 30, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub